Have a personal or library account? Click to login
Diagnosis and Treatment of Pityriasis Rubra Pilaris Cover
Open Access
|Apr 2015

References

  1. 1. Katsambas A, Lotti T, editors. European handbook of dermatological treatments. 2nd ed. Berlin, Heidelberg: Springer; 2003.10.1007/978-3-662-07131-1
  2. 2. Pincus DJ. Pityriasis rubra pilaris: a clinical review. Dermatol Nurs 2005;17(6):448-51.
  3. 3. Naciri Bennani B, Cheikh Rouhou H, Waton J, Cuny JF, Bassegoda G, Trechot P, et al. Pityriasis rubra pilaris after vaccination. Ann Dermatol Venereol 2011;138(11):753-6.10.1016/j.annder.2011.01.04922078037
  4. 4. Judge MR, McLean WHI, Munro CS. Disorders of keratinization. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's textbook of dermatology. 8th ed. Oxford: Blackwell Publishing Ltd; 2010. p. 19.1-19.122.10.1002/9781444317633.ch19
  5. 5. Tarral C. General psoriasis. Desquamation from the parts covered with hair. In: Rayer P. A theoretical and practical treatise on the diseases of the skin. 2nd edn. London: Baillière; 1835. p. 648-9.
  6. 6. Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980;5:105-12.10.1111/j.1365-2230.1980.tb01676.x7398119
  7. 7. Pitman J, Muekusch G. Pityriasis rubra pilaris. Dermatol Nurs 2005;17(4):302.
  8. 8. Besnier E. Observations pour servir a l'histoire clinique du pityriasis rubra pilaire. Ann Dermatol Syphiligr (Paris) 1889;10:253-87.
  9. 9. Moore T. Vitamin A and carotene: the absence of the liver oil vitamin A from carotene. VI. The conversion of carotene to vitamin A in vivo. Biochem J 1930;24(3):692-702.10.1042/bj0240692125451116744410
  10. 10. Lynde CW, Kraft JN, Lyndec B. Acitretin revisited. Skin Therapy Lett 2011;16(3):1-4.
  11. 11. Carretero G, Rinera M, Belinchon I, Carrascosa JM, Puig L, Ferrandiz C, et al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr 2013;104(7):598-616.10.1016/j.ad.2013.01.003
  12. 12. Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol 2006;142:1000-4.10.1001/archderm.142.8.100016924049
  13. 13. Berbis P. Acitretine. Ann Dermatol Venereol 2001;128(6-7):737-45.
  14. 14. Estival JL, Dupin M, Kanitakis J, Combemale P. Capillary leak syndrome induced by acitretin. Br J Dermatol 2004;150(1):150-2.10.1111/j.1365-2133.2004.05771.x14746632
  15. 15. Holliday AC, Megan NM, Berlingeri-Ramos A. Methotrexate: role of treatment in skin disease. Skin Therapy Lett 2013;18(3):4-9.
  16. 16. Osório F, Magina S. Phototherapy and photopheresis. Expert Rev Dermatol 2011;6(6):613-23.10.1586/edm.11.71
  17. 17. Gemmeke A, Schönlebe J, Koch A, Wollina U. Pityriasis rubra pilaris a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2010;8(6):439-44.10.1111/j.1610-0387.2010.07338.x20202046
Language: English
Page range: 167 - 173
Published on: Apr 4, 2015
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Alexey Kubanov, Yulia Gallyamova, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.